In this research, we explored the expression level of CDK6 in stomach cancer and the regulation of CDK4/6 inhibitor PD-0332991 on stomach cancer cell proliferation, aimed at providing more promising targets for stomach cancer. This evidence concerns the gene CDK6 and gastric neoplasm.